Regulation of miR-200c by nuclear receptors PPARα, LRH-1 and SHP

Biochemical and Biophysical Research Communications

Volumn 416, Issue 1-2, 2011, Pages 135-139

  Zhang, Yuxia ^a   Yang, Zhihong ^a   Whitby, Richard ^b   Wang, Li ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Cell migration; MicroRNA; Nuclear receptor; Transcription

Indexed keywords

CELL PROTEIN; LIVER RECEPTOR HOMOLOG 1; MICRORNA; MICRORNA 200C; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN TYROSINE PHOSPHATASE SHP; PROTEIN ZEB1; PROTEIN ZEB2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; GENE EXPRESSION; GENE FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICRORNAS; PPAR ALPHA; PROMOTER REGIONS, GENETIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ACTIVATION;

EID: 83055169260     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.11.011     Document Type: Article

References (30)

1. Wang Y., Weng T., Gou D., Chen Z., Chintagari N.R., Liu L. Identification of rat lung-specific microRNAs by micoRNA microarray: valuable discoveries for the facilitation of lung research. BMC Genomics 2007, 8:29.
2. Hurteau G.J., Carlson J.A., Spivack S.D., Brock G.J. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res. 2007, 67:7972-7976.
3. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., Vadas M.A., Khew-Goodall Y., Goodall G.J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008, 10:593-601.
4. Burk U., Schubert J., Wellner U., Schmalhofer O., Vincan E., Spaderna S., Brabletz T. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008, 9:582-589.
5. D.R. Cochrane, N.S. Spoelstra, E.N. Howe, S.K. Nordeen, J.K. Richer, MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Mol. Cancer Ther., 2009.
6. Ceppi P., Mudduluru G., Kumarswamy R., Rapa I., Scagliotti G.V., Papotti M., Allgayer H. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol. Cancer Res. 2010, 8:1207-1216.
7. Xi Y., Formentini A., Chien M., Weir D.B., Russo J.J., Ju J., Kornmann M., Ju J. Prognostic values of microRNAs in colorectal cancer. Biomarkers Insights 2006, 2:113-121.
8. Iorio M.V., Visone R., Di Leva G., Donati V., Petrocca F., Casalini P., Taccioli C., Volinia S., Liu C.G., Alder H., Calin G.A., Menard S., Croce C.M. MicroRNA signatures in human ovarian cancer. Cancer Res. 2007, 67:8699-8707.
9. Mees S.T., Mardin W.A., Wendel C., Baeumer N., Willscher E., Senninger N., Schleicher C., Colombo-Benkmann M., Haier J. EP300 - a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. Int. J. Cancer 2010, 126:114-124.
10. Nakada C., Matsuura K., Tsukamoto Y., Tanigawa M., Yoshimoto T., Narimatsu T., Nguyen L.T., Hijiya N., Uchida T., Sato F., Mimata H., Seto M., Moriyama M. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J. Pathol. 2008, 216:418-427.
11. Schickel R., Park S.M., Murmann A.E., Peter M.E. miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1. Mol. Cell 2010, 38:908-915.
12. Shimono Y., Zabala M., Cho R.W., Lobo N., Dalerba P., Qian D., Diehn M., Liu H., Panula S.P., Chiao E., Dirbas F.M., Somlo G., Pera R.A., Lao K., Clarke M.F. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009, 138:592-603.
13. Wellner U., Schubert J., Burk U.C., Schmalhofer O., Zhu F., Sonntag A., Waldvogel B., Vannier C., Darling D., zur Hausen A., Brunton V.G., Morton J., Sansom O., Schuler J., Stemmler M.P., Herzberger C., Hopt U., Keck T., Brabletz S., Brabletz T. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol. 2009, 11:1487-1495.
14. Vrba L., Jensen T.J., Garbe J.C., Heimark R.L., Cress A.E., Dickinson S., Stampfer M.R., Futscher B.W. Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS One 2010, 5:e8697.
15. Neves R., Scheel C., Weinhold S., Honisch E., Iwaniuk K.M., Trompeter H.I., Niederacher D., Wernet P., Santourlidis S., Uhrberg M. Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells. BMC Res. Notes 2010, 3:219.
16. E.D. Wiklund, J.B. Bramsen, T. Hulf, L. Dyrskjot, R. Ramanathan, T.B. Hansen, S.B. Villadsen, S. Gao, M.S. Ostenfeld, M. Borre, M.E. Peter, T.F. Orntoft, J. Kjems, S.J. Clark, Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int. J. Cancer., 2010.
17. Kim H.B., Kumar A., Wang L., Liu G.H., Keller S.R., Lawrence J.C., Finck B.N., Harris T.E. Lipin 1 represses NFATc4 transcriptional activity in adipocytes to inhibit secretion of inflammatory factors. Mol. Cell Biol. 2010, 30:3126-3139.
18. Chakravarthy M.V., Lodhi I.J., Yin L., Malapaka R.R., Xu H.E., Turk J., Semenkovich C.F. Identification of a physiologically relevant endogenous ligand for PPARalpha in liver. Cell 2009, 138:476-488.
19. Y. Zhang, J. Soto, K. Park, G. Viswanath, S. Kuwada, E.D. Abel, L. Wang, Nuclear receptor SHP, a death receptor that targets mitochondria, induces apoptosis and inhibits tumor growth. Mol. Cell Biol., 2010.
20. Song G., Zhang Y., Wang L. MicroRNA-206 targets notch3, Activates apoptosis, and inhibits tumor cell migration and focus formation. J. Biol. Chem. 2009, 284:31921-31927.
21. Whitby R.J., Dixon S., Maloney P.R., Delerive P., Goodwin B.J., Parks D.J., Willson T.M. Identification of small molecule agonists of the orphan nuclear receptors liver receptor homolog-1 and steroidogenic factor-1. J. Med. Chem. 2006, 49:6652-6655.
22. Whitby R.J., Stec J., Blind R.D., Dixon S., Leesnitzer L.M., Orband-Miller L.A., Williams S.P., Willson T.M., Xu R., Zuercher W.J., Cai F., Ingraham H.A. Small molecule agonists of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2). J. Med. Chem. 2010, 54:2266-2281.
23. Bendoraite A., Knouf E.C., Garg K.S., Parkin R.K., Kroh E.M., O'Briant K.C., Ventura A.P., Godwin A.K., Karlan B.Y., Drescher C.W., Urban N., Knudsen B.S., Tewari M. Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. Gynecol. Oncol. 2010, 116:117-125.
24. Y. Zhang, C.H. Hagedorn, L. Wang, Role of nuclear receptor SHP in metabolism and cancer. Biochim. Biophys. Acta., 2011.
25. Zhou T., Zhang Y., Macchiarulo A., Yang Z., Cellanetti M., Coto E., Xu P., Pellicciari R., Wang L. Novel polymorphisms of nuclear receptor SHP associated with functional and structural changes. J. Biol. Chem. 2010, 285:24871-24881.
26. Song G., Wang L. Transcriptional mechanism for the paired miR-433 and miR-127 genes by nuclear receptors SHP and ERRgamma. Nucleic Acids Res. 2008, 36:5727-5735.
27. Song G., Wang L. A conserved gene structure and expression regulation of miR-433 and miR-127 in mammals. PLoS One 2009, 4:e7829.
28. Cao P., Deng Z., Wan M., Huang W., Cramer S.D., Xu J., Lei M., Sui G. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta. Mol. Cancer 2010, 9:108.
29. Yin K.J., Deng Z., Hamblin M., Xiang Y., Huang H., Zhang J., Jiang X., Wang Y., Chen Y.E. Peroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury. J. Neurosci. 2010, 30:6398-6408.
30. F.U. Weiss, I.J. Marques, J.M. Woltering, D.H. Vlecken, A. Aghdassi, L.I. Partecke, C.D. Heidecke, M.M. Lerch, C.P. Bagowski, Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer, Gastroenterology 137 (2009) 2136e1-2145e-7.